Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
Grinsztejn, Beatriz, Prof, De Castro, Nathalie, MD, Arnold, Vincent, PhD, Veloso, Valdiléa G, Prof, Morgado, Mariza, Prof, Pilotto, José Henrique, PhD, Brites, Carlos, Prof, Madruga, José Valdez, MSc, Barcellos, Nêmora Tregnago, PhD, Santos, Breno Riegel, MD, Vorsatz, Carla, MD, Fagard, Catherine, MD, Santini-Oliveira, Marilia, PhD, Patey, Olivier, MD, Delaugerre, Constance, PhD, Chêne, Geneviève, Prof, Molina, Jean-Michel, Prof
Published in The Lancet infectious diseases (01.06.2014)
Published in The Lancet infectious diseases (01.06.2014)
Get full text
Journal Article